LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel: Oral administration of a casein matrix containing β-casofensin protects the intestinal barrier in two preclinical models of gut diseases

Bessette, Claudine / Bérengère Benoit / Emmanuelle Meugnier / Gwénaële Henry / Jérémie Bruno / Joelle Léonil / Laurent Ferrier / Pascale Plaisancié / Soraya Sekkal / Vassilia Théodorou

Journal of functional foods. 2016 Dec., v. 27

2016  

Abstract: β-Casofensin is a milk-derived bioactive peptide that interacts with intestinal goblet cells. We aimed to determine whether β-casofensin could prevent intestinal dysfunctions induced by neonatal maternal separation (NMS) and whether it retains its ... ...

Abstract β-Casofensin is a milk-derived bioactive peptide that interacts with intestinal goblet cells. We aimed to determine whether β-casofensin could prevent intestinal dysfunctions induced by neonatal maternal separation (NMS) and whether it retains its protective effects when administered in a casein matrix. We also evaluated whether a casein matrix enriched in β-casofensin protects against intestinal enteritis induced by indomethacin. β-Casofensin abolished NMS-induced jejunal hyperpermeability and prevented the depletion of goblet and Paneth cells induced by NMS. In addition, β-casofensin maintained its effectiveness against NMS-induced intestinal barrier alterations when administered in a casein matrix. A casein matrix containing β-casofensin also reduced intestinal damages induced by indomethacin. A functional food containing β-casofensin may prevent both the deleterious effects of neonatal stress on the intestinal barrier and indomethacin-induced enteritis. These results suggest a promising application of β-casofensin as a gut barrier protector in the context of bioactive foods and clinical nutrition.
Schlagwörter absorption barrier ; casein ; clinical nutrition ; enteritis ; functional foods ; goblet cells ; indomethacin ; jejunum ; models ; oral administration ; protective effect
Sprache Englisch
Erscheinungsverlauf 2016-12
Umfang p. 223-235.
Erscheinungsort Elsevier Ltd
Dokumenttyp Artikel
ZDB-ID 2511964-3
ISSN 1756-4646
ISSN 1756-4646
DOI 10.1016/j.jff.2016.09.007
Signatur
Z 7830: Hefte anzeigen
Datenquelle NAL Katalog (AGRICOLA)

Zusatzmaterialien

Kategorien

Zum Seitenanfang